{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:08:57Z","timestamp":1775930937919,"version":"3.50.1"},"reference-count":42,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100007297","name":"IIUM","doi-asserted-by":"publisher","award":["IIUM\/504\/G\/14\/3\/1\/1\/RMGS24-007-0038"],"award-info":[{"award-number":["IIUM\/504\/G\/14\/3\/1\/1\/RMGS24-007-0038"]}],"id":[{"id":"10.13039\/501100007297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonfunctioning pituitary neuroendocrine tumors (NF-PitNETs) display considerable biological heterogeneity, posing challenges for accurate prognostication and personalized management. This systematic review, conducted in Scopus and Web of Science in accordance with PRISMA 2020, identified 29 primary studies and categorized all molecular findings into 3 core themes: (1) invasion biology and epithelial\u2013mesenchymal transition (EMT); (2) noncoding RNAs and liquid biopsy markers; and (3) multiomics, epigenetic, and prognostic signatures.<\/jats:p>\n                  <jats:p>Within the invasion\/EMT theme, gonadotroph tumors consistently demonstrated the strongest EMT-linked activity, including SNAI-mediated transitions, Vimentin upregulation, and \u03b2-catenin alterations. Corticotroph tumors showed intermediate EMT involvement, while null-cell tumors exhibited invasion patterns driven mainly by hypoxia-related protease dysregulation rather than EMT. In the noncoding RNA and circulating biomarker theme, several candidates, including exosomal miR-486-5p, miR-151a-5p, and exosomal MMP1, have shown diagnostic or prognostic value, although subtype specificity remains limited. The multiomics and epigenetic theme revealed subtype-dependent molecular programs: gonadotroph tumors were associated with PI3K\u2013AKT pathway enrichment and SF-1 labeling heterogeneity; recurrent lesions showed elevated nuclear pEGFR T693 and MCM7; while DNA methylation mapping identified subtype-relevant loci such as NUP93, LGALS1, and GABRA1. Phosphoproteomic and acetylomic profiling further highlighted alterations in metabolic, kinase-driven, and cell-adhesion pathways linked to invasion and recurrence. Overall, the lineage-aligned synthesis indicates that NF-PitNETs progress through diverse molecular pathways, with each subtype dominated by distinct regulatory networks. Although many biomarkers show promise, most remain exploratory, highlighting the need for harmonized methods and multicenter validation to support precision diagnostics and prognostic modeling.<\/jats:p>","DOI":"10.1210\/clinem\/dgaf650","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:08:46Z","timestamp":1764767326000},"page":"e1195-e1204","source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers Driving Precision Medicine in Nonfunctioning Pituitary Neuroendocrine Tumors: A Systematic Review of Recent Literature"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-8824","authenticated-orcid":false,"given":"Amalina","family":"Haydar Ali Tajuddin","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kulliyyah of Medicine, International Islamic University Malaysia , Kuantan, Pahang 25200 ,","place":["Malaysia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Firdaus","family":"Isa","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Kulliyyah of Science, International Islamic University Malaysia , Kuantan, Pahang 25200 ,","place":["Malaysia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Hamzah","family":"Mohd Nasir","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Kulliyyah of Science, International Islamic University Malaysia , Kuantan, Pahang 25200 ,","place":["Malaysia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"4","key":"2026031619580862400_dgaf650-B1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10014-022-00441-6","article-title":"Aggressive nonfunctioning pituitary neuroendocrine tumors","volume":"39","author":"Portovedo","year":"2022","journal-title":"Brain Tumor Pathol"},{"issue":"6","key":"2026031619580862400_dgaf650-B2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3803\/EnM.2023.1838","article-title":"Update on current evidence for the diagnosis and management of nonfunctioning pituitary neuroendocrine tumors","volume":"38","author":"Whyte","year":"2023","journal-title":"Endocrinol Metab"},{"issue":"3","key":"2026031619580862400_dgaf650-B3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13167-021-00246-1","article-title":"Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies","volume":"12","author":"Aydin","year":"2021","journal-title":"EPMA J"},{"key":"2026031619580862400_dgaf650-B4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mce.2019.04.010","article-title":"Differential expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors","volume":"490","author":"Portovedo","year":"2019","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"2026031619580862400_dgaf650-B5","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.3390\/ijms23095122","article-title":"Circulating noncoding RNAs in pituitary neuroendocrine tumors\u2014two sides of the same coin","volume":"23","author":"Butz","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2026031619580862400_dgaf650-B6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41574-024-01005-8","article-title":"Circulating non-coding RNA biomarkers of endocrine tumours","volume":"20","author":"Butz","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"2026031619580862400_dgaf650-B7","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.3390\/ijms26094058","article-title":"Liquid biopsy in pituitary neuroendocrine tumors\u2014potential biomarkers for diagnosis, prognosis, and therapy","volume":"26","author":"Tataranu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026031619580862400_dgaf650-B8","doi-asserted-by":"crossref","first-page":"149374","DOI":"10.1016\/j.gene.2025.149374","article-title":"GALR1 and PENK serve as potential biomarkers in invasive non-functional pituitary neuroendocrine tumours","volume":"950","author":"Wu","year":"2025","journal-title":"Gene"},{"issue":"12","key":"2026031619580862400_dgaf650-B9","doi-asserted-by":"crossref","first-page":"bvaa157","DOI":"10.1210\/jendso\/bvaa157","article-title":"Estrogen receptors in nonfunctioning pituitary neuroendocrine tumors: review on expression and gonadotroph functions","volume":"4","author":"Haydar Ali Tajuddin","year":"2020","journal-title":"J Endocr Soc"},{"key":"2026031619580862400_dgaf650-B10","doi-asserted-by":"crossref","first-page":"1131693","DOI":"10.3389\/fendo.2023.1131693","article-title":"Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment","volume":"14","author":"Wu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026031619580862400_dgaf650-B11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00701-024-05977-4","article-title":"Is radiomics a useful addition to magnetic resonance imaging in the preoperative classification of PitNETs?","volume":"166","author":"Sathya","year":"2024","journal-title":"Acta Neurochir"},{"issue":"3","key":"2026031619580862400_dgaf650-B12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/XEB.0000000000000062","article-title":"Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation","volume":"13","author":"Lockwood","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"4","key":"2026031619580862400_dgaf650-B13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.21860\/medflum2021_264903","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"57","author":"Page","year":"2021","journal-title":"Med Flum"},{"issue":"9","key":"2026031619580862400_dgaf650-B14","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.3390\/ijms26094408","article-title":"MicroRNA is downregulated in invasive non-functioning pituitary adenomas","volume":"26","author":"Derwich-Rudowicz","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2026031619580862400_dgaf650-B15","first-page":"e240146","article-title":"Activation of the HIF1\u03b1\/TIMP1\/MT6-MMP pathway is associated with invasion in pituitary null cell adenomas","volume":"32","author":"Yu","year":"2025","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2026031619580862400_dgaf650-B16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12672-024-01338-w","article-title":"Expression assays of selected lncRNAs in non-functioning pituitary adenomas","volume":"15","author":"Esmaeili Motlagh","year":"2024","journal-title":"Discov Oncol"},{"issue":"15","key":"2026031619580862400_dgaf650-B17","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.3390\/jcm13154409","article-title":"KLHL14 and E-cadherin nuclear co-expression as predicting factor of nonfunctioning PitNET invasiveness: preliminary study","volume":"13","author":"Berardinelli","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"2026031619580862400_dgaf650-B18","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/clinem\/dgad767","article-title":"Proteomic profiles associated with postsurgical progression in nonfunctioning pituitary adenomas","volume":"109","author":"Hall\u00e9n","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031619580862400_dgaf650-B19","doi-asserted-by":"crossref","first-page":"1129213","DOI":"10.3389\/fendo.2023.1129213","article-title":"Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors","volume":"14","author":"Gil","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026031619580862400_dgaf650-B20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40478-022-01441-5","article-title":"Phosphorylation of \u03b2-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours","volume":"10","author":"Rai","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2026031619580862400_dgaf650-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-021-00919-y","article-title":"Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas","volume":"22","author":"Khamseh","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"2026031619580862400_dgaf650-B22","doi-asserted-by":"crossref","first-page":"978016","DOI":"10.3389\/fonc.2022.978016","article-title":"Expression pattern of non-coding RNAs in non-functioning pituitary adenoma","volume":"12","author":"Ghafouri-Fard","year":"2022","journal-title":"Front Oncol"},{"key":"2026031619580862400_dgaf650-B23","doi-asserted-by":"crossref","first-page":"901647","DOI":"10.3389\/fonc.2022.901647","article-title":"Expression and clinical significance of Cathepsin K and MMPs in invasive non-functioning pituitary adenomas","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"issue":"8","key":"2026031619580862400_dgaf650-B24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/clinem\/dgac266","article-title":"Genome-wide DNA methylation differences in nonfunctioning pituitary adenomas with and without postsurgical progression","volume":"107","author":"Hall\u00e9n","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026031619580862400_dgaf650-B25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12020-022-03051-6","article-title":"Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours","volume":"77","author":"Oystese","year":"2022","journal-title":"Endocrine"},{"key":"2026031619580862400_dgaf650-B26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2022.01.014","article-title":"Diagnosis of invasive non-functional pituitary adenomas using exosomal biomarkers","volume":"529","author":"Ren","year":"2022","journal-title":"Clin Chim Acta"},{"key":"2026031619580862400_dgaf650-B27","doi-asserted-by":"crossref","first-page":"771354","DOI":"10.3389\/fcell.2021.771354","article-title":"Exosomal miRNA profiling is a potential screening route for non-functional pituitary adenoma","volume":"9","author":"Lyu","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2026031619580862400_dgaf650-B28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4132\/jptm.2021.08.31","article-title":"Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas","volume":"56","author":"Kum","year":"2022","journal-title":"J Pathol Transl Med"},{"issue":"1","key":"2026031619580862400_dgaf650-B29","doi-asserted-by":"crossref","first-page":"20943","DOI":"10.1038\/s41598-021-00431-2","article-title":"Nkx3-1 and fech genes might be switch genes involved in pituitary non-functioning adenoma invasiveness","volume":"11","author":"Khayer","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"2026031619580862400_dgaf650-B30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12957-021-02383-3","article-title":"Potential biomarkers of miRNA in non-functional pituitary adenomas","volume":"19","author":"Zhang","year":"2021","journal-title":"World J Surg Oncol"},{"key":"2026031619580862400_dgaf650-B31","doi-asserted-by":"crossref","first-page":"753606","DOI":"10.3389\/fendo.2021.753606","article-title":"Quantitative acetylomics revealed acetylation-mediated molecular pathway network changes in human nonfunctional pituitary neuroendocrine tumors","volume":"12","author":"Wen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026031619580862400_dgaf650-B32","doi-asserted-by":"crossref","first-page":"708111","DOI":"10.3389\/fendo.2021.708111","article-title":"Phosphorylated EGFR (pEGFR T693) as a novel predictor of recurrence in non-functioning pituitary adenomas","volume":"12","author":"Rai","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2026031619580862400_dgaf650-B33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1530\/EJE-20-1086","article-title":"MCM7 as a marker of postsurgical progression in non-functioning pituitary adenomas","volume":"184","author":"Hall\u00e9n","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026031619580862400_dgaf650-B34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/nan.12675","article-title":"Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathway","volume":"47","author":"Hickman","year":"2021","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2026031619580862400_dgaf650-B35","doi-asserted-by":"crossref","first-page":"118416","DOI":"10.1016\/j.lfs.2020.118416","article-title":"Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry","volume":"260","author":"Hattori","year":"2020","journal-title":"Life Sci"},{"issue":"3","key":"2026031619580862400_dgaf650-B36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13167-020-00215-0","article-title":"Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas","volume":"11","author":"Liu","year":"2020","journal-title":"EPMA J"},{"issue":"3","key":"2026031619580862400_dgaf650-B37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12020-020-02366-6","article-title":"Cell proliferation, apoptosis, and angiogenesis in non-functional pituitary adenoma: association with tumor invasiveness","volume":"69","author":"Ghadir","year":"2020","journal-title":"Endocrine"},{"issue":"1","key":"2026031619580862400_dgaf650-B38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12022-019-09598-x","article-title":"A novel expression profile of cell cycle and DNA repair proteins in nonfunctioning pituitary adenomas","volume":"31","author":"Metin-Armagan","year":"2020","journal-title":"Endocr Pathol"},{"issue":"2","key":"2026031619580862400_dgaf650-B39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/CBM-191121","article-title":"Molecular alterations in non-functioning pituitary adenomas","volume":"28","author":"Taniguchi-Ponciano","year":"2020","journal-title":"Cancer Biomark"},{"issue":"1","key":"2026031619580862400_dgaf650-B40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7150\/thno.47525","article-title":"Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics","volume":"11","author":"Bao","year":"2021","journal-title":"Theranostics"},{"key":"2026031619580862400_dgaf650-B41","author":"Kitchenham"},{"key":"2026031619580862400_dgaf650-B42","doi-asserted-by":"crossref","first-page":"106316","DOI":"10.1016\/j.infsof.2020.106316","article-title":"Model composition in model driven engineering: a systematic literature review","volume":"125","author":"Abouzahra","year":"2020","journal-title":"Inf Softw Technol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf650\/65736652\/dgaf650.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/e1195\/65736652\/dgaf650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/e1195\/65736652\/dgaf650.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:58:34Z","timestamp":1773705514000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/4\/e1195\/8364809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,4]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf650","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,12,4]]}}}